JCP

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
[Advanced]

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Takemura, Y
Right arrow Articles by Beck, J R
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Takemura, Y
Right arrow Articles by Beck, J R
Right arrowPubmed/NCBI databases
Medline Plus Health Information
*Managed Care
J Clin Pathol 2001; 54:89-95
© 2001 Journal of Clinical Pathology


Leader

Laboratory testing under managed care dominance in the USA

Y Takemura, J R Beck

Pathology and Information Technology Programme, Baylor College of Medicine, One Baylor Plaza, Room 126E, Texas Medical Centre, Houston, Texas 77030–3498, USA

Dr Takemura, Department of Laboratory Medicine, National Defense Medical College, 3–2 Namiki, Tokorozawa, Saitama 359–8513, Japan yutakemu{at}interlink.or.jp The uncontrolled escalation of total health care expenditure despite the government's endeavours during the past decades in the USA had led to the rapid infiltration of managed care organisations (MCOs). Traditional hospital based laboratories have been placed in a crucial situation with the advent of the managed care era. A massive reduction of in house testing urged them to develop strategies against financial difficulty. Consolidation and networking, participation in the outreach testing market, and emphasis on point of care/satellite laboratory testing in non-traditional, ambulatory settings are major strategies for the survival of hospital laboratories. Several physicians' office laboratories (POLS) have closed their doors in response both to regulatory restrictions imposed by the Clinical Laboratory Improvement Amendments of 1988 and to managed care infiltration. It seems likely that POLs and hospital laboratories will continue to reduce test volumes, whereas commercial reference laboratories will thrive through contracting with MCOs. In the current climate of managed care dominance in the USA, clinical laboratories are changing their basic operation focus and mission in response to the aggressively changing landscape.

Key Words: laboratory testing • managed care organisations • survival strategies




This article has been cited by other articles:


Home page
Clin. Chem.Home page
Y. Takemura, H. Ishida, Y. Inoue, and J. R. Beck
Yield and Cost of Individual Common Diagnostic Tests in New Primary Care Outpatients in Japan
Clin. Chem., January 1, 2002; 48(1): 42 - 54.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS REGISTER
Journal of Clinical Pathology Molecular Pathology
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2001 by the BMJ Publishing Group Ltd & Association of Clinical Pathologists.